Allogene Therapeutics Reports First Quarter 2021 Financial ResultsĀ 

Go back to Allogene Therapeutics Reports First Quarter 2021 Financial ResultsĀ 
(NASDAQ: ALLO) Delayed: 2.17 +0.14 (6.90%)
Previous Close $2.03    52 Week High
Open $2.05    52 Week Low
Day High $2.21    P/E N/A 
Day Low $2.05    EPS
Volume 5,052,490